Effect of Denosumab on Glucose Homeostasis in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors: A Pilot Study.

Similarly, none of the calculated indexes was affected by Dmab ( Table 2 ), though HOMA-IR and insulinogenic indexes showed a trend toward reduction (2.01 ± 1.52 versus 1.81 ± 1.05; p =0.27 and 0.78 ± 0.64 versus 0.64 ± 0.48; p =0.45, respectively), while Matsuda and QUICKI Indexes showed a nonsignificant trend to increase (5.79 ± 3.51 versus 7.64 ± 8.58; p =0.26 and 0.362 ± 0.043 versus 0.365 ± 0.042; p =0.51, respectively).

also in 5,406 other papers